Because immunostaining of tumor cells for CD20 was not characteristic of DLBCL, histopathology was re-examined, and IHC analysis revealed that the tumor cells were strongly positive for CD38 and CD138 (Fig. 4a, b). The gene discussed is CD38; the disease is neoplasm.